Internal Medicine · New York, NY
NPI
1235542010
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
17 E 102nd St
New York, NY, 10029
Phone (212) 659-8551
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$147K
3,062 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Maria I Duenas prescribed most often to Medicare patients was Gabapentin, with 152 prescriptions and refills. In total Maria I Duenas wrote 3,062 Medicare prescriptions that cost $147K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gabapentin Generic | 152 | 227 | 42 | $2,599 |
| Atorvastatin Calcium Generic | 146 | 401 | 52 | $2,406 |
| Losartan Potassium Generic | 84 | 211 | 24 | $1,370 |
| Pantoprazole Sodium Generic | 78 | 140 | 23 | $1,312 |
| Furosemide Generic | 71 | 132 | 18 | $1,110 |
| Rosuvastatin Calcium Generic | 67 | 149 | 18 | $1,174 |
| Metoprolol Succinate Generic | 58 | 158 | 17 | $952 |
| Amlodipine Besylate Generic | 56 | 137 | 18 | $885 |
| Trulicity Dulaglutide | 54 | 59 | Under 11 | $20K |
| Tamsulosin Hcl Generic | 52 | 112 | 18 | $915 |
| Omeprazole Generic | 50 | 99 | 16 | $803 |
| Levothyroxine Sodium Generic | 47 | 113 | 14 | $826 |
| Latanoprost Generic | 46 | 48 | Under 11 | $755 |
| Fluticasone Propionate Generic | 44 | 60 | 24 | $793 |
| Omega-3 Acid Ethyl Esters Generic | 44 | 69 | 11 | $976 |
Brand drugs: 817 claims; generic drugs: 2,209 claims; opioid claims: 63.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Maria I Duenas were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.